CClinicalTrials.gg
RecruitingNCT05901675EMPUpdated Apr 15, 2026

EMPOWER: Effects of Weight Loss and Exercise Post-stroke

An interventional study of Lifestyle Management Program and Post-stroke Optimization of Walking using Explosive Resistance in Obesity and Stroke, sponsored by Medical University of South Carolina. Recruiting at 1 site in United States. Open to participants aged 35 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
35 Years to 85 Years
Sex
All
01

Study summary

The prevalence of obesity among U.S. adults is \~40% and is projected to climb. It is well documented that obesity is associated with increased levels of disability as well as risk for numerous adverse health-related outcomes; including occurrence of stroke and all-cause mortality. Obesity is highly prevalent in stroke survivors (\~30-45% of stroke survivors have BMI>30) and is associated with reductions in physical function and increased disability. Furthermore, neurological sequelae following stroke result in a myriad of residual impairments that contribute to significant reductions in physical activity, which further increase the risk for obesity. The alarmingly high (and increasing) rates of obesity amongst stroke survivors represents an area of critical clinical need and, despite an abundance of information regarding weight loss approaches in neurologically healthy individuals, there is a lack of information regarding the impact of intentional weight loss on overweight and obese survivors of stroke. Thus, the purpose of this study it investigate the effect of varying weight loss approaches on physical function and psychosocial outcomes in chronic stroke survivors.

Read the detailed description

With a surviving cohort of nearly 7 million individuals, stroke is the leading cause of long-term disability in the United States. Of the \~795,000 new strokes occurring in the U.S. each year, approximately two-thirds of survivors will have some degree of long term disability, and less than half will progress to independent community ambulation. Even among those who do achieve independent ambulation, significant residual deficits persist, with more than 60% of persons post-stroke reporting limitations in mobility related to walking. Concurrently, obesity is highly prevalent in stroke survivors (\~30-45% of stroke survivors have BMI>30) and is associated with increased levels of disability as well as risk for numerous adverse health-related outcomes; including re-occurrence of stroke and all-cause mortality.8 The neurological sequelae following stroke result in a myriad of residual impairments that contribute to significant reductions in physical activity, which further increase the risk for obesity. The alarmingly high (and increasing) rates of obesity amongst stroke survivors represents an area of critical clinical need and, despite an abundance of information regarding weight loss approaches in neurologically healthy individuals, there is a lack of information regarding the impact of intentional weight loss on obese survivors of stroke.

The proposed approach is an opportunity to address the all-to-common problem of post-stroke obesity. In an effort to reduce the long-term risk for disability and development or worsening of comorbid conditions, we propose the Enhancing Mobility and Psychosocial function in Obese Chronic Stroke Survivors via Weight loss and ExeRcise (EMPOWER) trial. This trial leverages a 15-week multidisciplinary approach to weight loss, via an existing lifestyle and weight management program at MUSC Weight Management Center. We will study the effects of this weight loss program delivered with or without concurrent supervised exercise training as the catalyst by which remediation of physical and psychosocial impairments promote enhanced recovery. Intentional weight loss in individuals who are obese (non-stroke) has been repeatedly shown to increase functional capacity, reduce risk of cardiovascular event and improve health related quality of life. However, a knowledge gap currently exists related to the efficacy of weight loss strategies for stroke survivors who are obese. Several lines of evidence suggest the potential impact of successful treatment for obesity following stroke, including: a) pathophysiological consequences of obesity, b) epidemiological evidence that obesity increases disability and reduces quality of life following stroke and c) well-established benefits of weight loss in neurologically health individuals. In response, we seek to create an environment suitable for stroke survivors who are obese to participate in and realize the benefits from a comprehensive lifestyle and weight management program. The proposed lifestyle management program incorporates a highly structured dietary caloric restriction intervention, consisting primarily of meal replacements, integrated with education and behavior modification strategies. In addition, the proposed exercise training program has demonstrated efficacy for improving post-stroke functional performance. It is our expectation that results of the proposed trial will catalyze change in post-stroke rehabilitation and recovery care for local stroke survivors who are obese, as well as the \~800,000 stroke survivors/year worldwide, thereby reducing the global burden of post-stroke disability.

02

Conditions studied

  • Obesity
  • Stroke

Keywords

  • Weight Loss
  • Exercise
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,695 are open to participants now.

This study's planned enrollment of 130 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. age 35-85
  2. stroke at least 6-months prior
  3. residual paresis in the lower extremity (Fugl-Meyer LE motor score \<34)
  4. ability to walk without assistance and without an AFO during testing and training at speeds ranging from 0.2-0.8 m/s
  5. body mass index (BMI) greater than 25
  6. provision of informed consent. All subjects who meet criteria for training must complete an exercise tolerance test and be cleared for participation by the study physician.

Exclusion criteria

Exclusion Criteria:

  1. unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking
  2. history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during ADL's
  3. history of COPD or oxygen dependence
  4. preexisting neurological disorders, dementia or previous stroke
  5. history of major head trauma
  6. legal blindness or severe visual impairment
  7. history of psychosis or other Axis I disorder that is primary
  8. life expectancy \<1 yr
  9. severe arthritis or other problems that limit passive ROM
  10. history of DVT or pulmonary embolism within 6 months
  11. uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
  12. severe hypertension with systolic >200 mmHg and diastolic >110 mmHg at rest
  13. history of seizures or currently prescribed anti-seizure medications
  14. current enrollment in a clinical trial to enhance motor recovery
  15. persons with child-bearing potential.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    DIET

    Focus-15 is a 15-week lifestyle change program developed and delivered by the Weight Management Center at the Medical University of South Carolina.

    Other: Lifestyle Management Program

  • Experimental
    DIET+Exercise

    As above with, the addition of supervised exercise. The investigators developed an innovative rehabilitation approach, Post-stroke Optimization of Walking using Explosive Resistance (POWER) training; a high-velocity, high-intensity lower extremity resistance training intervention that improves post-stroke muscular and locomotor function. POWER training will take place over a 12-week period (3 sessions/week) with exercises including leg press, calf raises, and jump training, all performed at high concentric velocity, as well as trials of fast walking and functional movements.

    Other: Lifestyle Management Program · Other: Post-stroke Optimization of Walking using Explosive Resistance

  • No intervention
    Wait-list Control

    Participants will undergo pre-, post- and follow-up testing but will not partake in any intervention during the same timeframe as those listed in the other arms. Participants will have the opportunity to be enrolled in one of the other arms once they have completed the WLC group timeframe.

Interventions

  • OtherLifestyle Management Program

    The program utilizes registered dietitians, exercise physiologists and psychologists and is designed to induce larger initial weight losses than traditional lifestyle change programs. The early part of the program provides a highly structured dietary intervention, which consists primarily of meal replacements provided to the participant as part of the program (shakes and nutrition bars). Gradually, as the program progresses, there is a shift towards a primarily food-based meal plan that leads to more moderate and sustainable weight loss. Throughout the program, participants attend weekly individual appointments that rotate among the clinical specialties (dietary and behavioral). The emphasis on lifestyle change means the goal is to help the participant learn to make healthy behavior changes that can be sustained long after completion of the program, thus enabling maintenance of a healthier weight.

  • OtherPost-stroke Optimization of Walking using Explosive Resistance

    POWER training will take place over a 12-week period (3 sessions/week) with exercises including leg press, calf raises, and jump training, all performed at high concentric velocity, as well as trials of fast walking and functional movements.

06

What researchers measure

Primary outcomes

  1. Physical Function

    Participating in a lifestyle management program (DIET or DIET+Ex) will improve performance on the six-minute walk test (6MWT) compared to those in the waitlist control and DIET groups.

    Time frame: 15 weeks

Secondary outcomes

  1. Psychosocial Outcomes

    Participating in a lifestyle management program (DIET+Ex or DIET) will improve across multiple domains of psychosocial function specific to post-stroke sequelae (vs. WLC + DIET), as indicated by total score on the Stroke Impact Scale (SIS).

    Time frame: 15 weeks

07

Study locations

1 of 1 sites recruiting
  • College of Health Professions
    Charleston, South Carolina 29425, United States
    • Ewan R Williams, PhD · Contact · williaew@musc.edu · 8437923477
    • Chris Gregory, PhD, PT · Principal investigator
    Recruiting
08

References and documents

Study documents

  • Informed consent form · Jun 6, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05901675
Lead sponsor
Medical University of South Carolina
Collaborators
US Department of Veterans Affairs
Responsible party
Chris Gregory (Professor-Faculty, Medical University of South Carolina) — Principal investigator
First posted
Jun 13, 2023
Start date
Jul 7, 2023
Primary completion
Oct 2027 (estimated)
Completion
Mar 2028 (estimated)
Last update
Apr 15, 2026

Study contacts

Ewan Willams, PhD
Contact
williaew@musc.edu
843-792-3477
Chris Gregory, PhD, PT
principal investigator · Medical University of South Carolina

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion